These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 38180451)

  • 21. Comparative Analysis of Risk Factors in Declined Kidneys from Donation after Brain Death and Circulatory Death.
    Zwaini Z; Patel M; Stover C; Dormer J; Nicholson ML; Hosgood SA; Yang B
    Medicina (Kaunas); 2020 Jun; 56(6):. PubMed ID: 32604873
    [No Abstract]   [Full Text] [Related]  

  • 22. The Role of Ex Situ Hypothermic Oxygenated Machine Perfusion and Cold Preservation Time in Extended Criteria Donation After Circulatory Death and Donation After Brain Death.
    Dondossola D; Ravaioli M; Lonati C; Maroni L; Pini A; Accardo C; Germinario G; Antonelli B; Odaldi F; Zanella A; Siniscalchi A; Cescon M; Rossi G
    Liver Transpl; 2021 Aug; 27(8):1130-1143. PubMed ID: 33835695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Early US experience with cardiac donation after circulatory death (DCD) using normothermic regional perfusion.
    Hoffman JRH; McMaster WG; Rali AS; Rahaman Z; Balsara K; Absi T; Levack M; Brinkley M; Menachem J; Punnoose L; Sacks S; Wigger M; Zalawadiya S; Stevenson L; Schlendorf K; Lindenfeld J; Shah AS
    J Heart Lung Transplant; 2021 Nov; 40(11):1408-1418. PubMed ID: 34334301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outcomes of Heart Transplant Donation After Circulatory Death.
    Siddiqi HK; Trahanas J; Xu M; Wells Q; Farber-Eger E; Pasrija C; Amancherla K; Debose-Scarlett A; Brinkley DM; Lindenfeld J; Menachem JN; Ooi H; Pedrotty D; Punnoose L; Rali AS; Sacks S; Wigger M; Zalawadiya S; McMaster W; Devries S; Shah A; Schlendorf K
    J Am Coll Cardiol; 2023 Oct; 82(15):1512-1520. PubMed ID: 37793748
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pediatric heart transplantation following donation after circulatory death, distant procurement, and ex-situ perfusion.
    Laurence C; Nachum E; Henwood S; Berman M; Large SR; Messer S; Kaul P; Baxter J; Quigley R; Osman M; Muthialu N; Davies B; Bohuta L; Kostolny M; Burch M; Fenton M; Andrews R; Thiruchelvam T; Hoskote A; Simmonds J
    J Heart Lung Transplant; 2022 Aug; 41(8):1104-1113. PubMed ID: 35641424
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Commonalities and Differences in Mitochondrial Dysfunction Between
    Quader M; Akande O; Toldo S; Cholyway R; Kang L; Lesnefsky EJ; Chen Q
    Front Physiol; 2020; 11():681. PubMed ID: 32714203
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Survival advantage for patients accepting the offer of a circulatory death liver transplant.
    Taylor R; Allen E; Richards JA; Goh MA; Neuberger J; Collett D; Pettigrew GJ;
    J Hepatol; 2019 May; 70(5):855-865. PubMed ID: 30639505
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Normothermic Regional Perfusion and Hypothermic Oxygenated Machine Perfusion for Livers Donated After Controlled Circulatory Death With Prolonged Warm Ischemia Time: A Matched Comparison With Livers From Brain-Dead Donors.
    Patrono D; Zanierato M; Vergano M; Magaton C; Diale E; Rizza G; Catalano S; Mirabella S; Cocchis D; Potenza R; Livigni S; Balagna R; Romagnoli R
    Transpl Int; 2022; 35():10390. PubMed ID: 35529593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Electron Transport Chain Inhibition to Decrease Injury in Transplanted Donation After Circulatory Death Rat Hearts.
    Quader M; Chen Q; Akande O; Cholyway R; Mezzaroma E; Lesnefsky EJ; Toldo S
    J Cardiovasc Pharmacol; 2023 Jun; 81(6):389-391. PubMed ID: 36995087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Loss of p47phox subunit enhances susceptibility to biomechanical stress and heart failure because of dysregulation of cortactin and actin filaments.
    Patel VB; Wang Z; Fan D; Zhabyeyev P; Basu R; Das SK; Wang W; Desaulniers J; Holland SM; Kassiri Z; Oudit GY
    Circ Res; 2013 Jun; 112(12):1542-56. PubMed ID: 23553616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Rat Model of Cardiac Donation After Circulatory Death Combined With Normothermic
    Li J; Xue C; Ling X; Xie Y; Pavan D; Chen H; Peng Q; Lin S; Li K; Zheng S; Zhou P
    Front Cardiovasc Med; 2021; 8():639701. PubMed ID: 34368241
    [No Abstract]   [Full Text] [Related]  

  • 32. Cold Crystalloid Perfusion Provides Cardiac Preservation Superior to Cold Storage for Donation After Circulatory Death.
    Choong JW; Ou R; Lim YW; Rosenfeldt FL
    Transplantation; 2016 Mar; 100(3):546-53. PubMed ID: 26569064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing the tolerance of DCD hearts to warm ischemia by pharmacological postconditioning.
    Iyer A; Gao L; Doyle A; Rao P; Jayewardene D; Wan B; Kumarasinghe G; Jabbour A; Hicks M; Jansz PC; Feneley MP; Harvey RP; Graham RM; Dhital KK; Macdonald PS
    Am J Transplant; 2014 Aug; 14(8):1744-52. PubMed ID: 25040306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitochondrial transplantation for myocardial protection in ex-situ‒perfused hearts donated after circulatory death.
    Guariento A; Doulamis IP; Duignan T; Kido T; Regan WL; Saeed MY; Hoganson DM; Emani SM; Fynn-Thompson F; Matte GS; Del Nido PJ; McCully JD
    J Heart Lung Transplant; 2020 Nov; 39(11):1279-1288. PubMed ID: 32703639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Missed opportunities for DCD kidney donors: Evaluation of warm ischemic time and associated functional warm ischemic time.
    Law J; Hornby K; Payne C; Sener A; Luke PP
    Clin Transplant; 2019 Nov; 33(11):e13724. PubMed ID: 31585486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting the NLRP3 inflammasome to reduce warm ischemic injury in donation after circulatory death heart.
    Quader M; Mezzaroma E; Kenning K; Toldo S
    Clin Transplant; 2020 Oct; 34(10):e14044. PubMed ID: 32654189
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Rodent Model of Cardiac Donation After Circulatory Death and Novel Biomarkers of Cardiac Viability During Ex Vivo Heart Perfusion.
    Kearns MJ; Miller SD; Cheung A; Bashir J; Wong S; Seidman MA; Boyd JH
    Transplantation; 2017 Aug; 101(8):e231-e239. PubMed ID: 28505025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathological characteristics of liver allografts from donation after brain death followed by cardiac death in pigs.
    Ye H; Wang DP; Zhang CZ; Zhang LJ; Wang HC; Li ZH; Chen Z; Zhang T; Cai CJ; Ju WQ; Ma Y; Guo ZY; He XS
    J Huazhong Univ Sci Technolog Med Sci; 2014 Oct; 34(5):687-691. PubMed ID: 25318878
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Warm Ischemia Time on Donation After Circulatory Death Kidney Transplant Outcomes.
    Alghannam K; Fine J; Howard B; Loza J; Goussous NM; Sageshima J; Mineyev NM; Wang AX; Perez RV; Than PA
    Clin Transplant; 2024 Aug; 38(8):e15436. PubMed ID: 39158959
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased myocardial NADPH oxidase activity in human heart failure.
    Heymes C; Bendall JK; Ratajczak P; Cave AC; Samuel JL; Hasenfuss G; Shah AM
    J Am Coll Cardiol; 2003 Jun; 41(12):2164-71. PubMed ID: 12821241
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.